Effect of ACTH on enzymatic defect produced in vivo by a competitive inhibitor of 3-beta-hydroxysteroid dehydrogenase.
D000311:Adrenal Glands / Q000187:drug effects / Q000201:enzymology*; D000312:Adrenal Hyperplasia, Congenital / Q000139:chemically induced; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology*; D000731:Androstanes / Q000494:pharmacology; D000818:Animals; D002247:Carbon Isotopes; D003486:Cyanides / Q000494:pharmacology; D004195:Disease Models, Animal; D005260:Female; D006913:Hydroxysteroid Dehydrogenases / Q000037:antagonists & inhibitors*; D007535:Isomerases / Q000037:antagonists & inhibitors*; D008661:Metabolism, Inborn Errors / Q000139:chemically induced*; D009929:Organ Size; D010080:Oxazoles / Q000494:pharmacology*; D010913:Pituitary-Adrenal System; D051381:Rats
D000731:Androstanes; D002247:Carbon Isotopes; D003486:Cyanides; D010080:Oxazoles; D000324:Adrenocorticotropic Hormone; D006913:Hydroxysteroid Dehydrogenases; D007535:Isomerases